💬In plain words
What the trial is, and whether it could suit you
This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
* Male or female, aged 16 or above
* Clinical diagnosis of tinea pedis (For Cohort 4, positive symptomology is acceptable)
* Confirmation of diagnosis with positive potassium hydroxide (KOH) microscopy (For Cohort 4, a negative KOH test is acceptable)
* Signed and dated informed consent form
* Willingness to comply with study protocol and availability for the duration of the study
Exclusion Criteria:
* Diagnosis of moccasin-type tinea pedis
* Presence of serous exudate or pus
* Treatment with a topical antifungal in the past 2 weeks
* Treatment with a systemic antifungal in the past 4 weeks
* Concurrent immunosuppressive or antimicrobial therapy
* Liver disease
* Pregnancy or breastfeeding
* Use any other antifungal therapy during trial or within three months of starting the trial
* Known hypersensitivity to any ingredients of trial agents
* Patients with a current diagnosis of diabetes or neuropathy
💊
What it tests
- 1% Tolnaftate Stick Formula A
- 1% Tolnaftate Stick Formula B
- 1% Tolnaftate Stick Formula C
Kuchnir Dermatology and Dermatological Surgery
Framingham, United States
Kuchnir Dermatology and Dermatological Surgery
Milford, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
HealthTeky